Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)

British Medical Journal

Volumn 320, Issue 7246, 2000, Pages 1368-1373

  Shrewsbury, Stephen ^a   Pyke, Stephen ^a   Britton, Mark ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ST PETER S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; FLUTICASONE; SALMETEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; META ANALYSIS; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034690661     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.320.7246.1368     Document Type: Article

References (16)

1. 1 British Guidelines on Asthma Management. 1995 review and position Statement. Thorax 1997;52(suppl 1):1-21.
2. 2 Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroids in asthma patients. Lancet 1994;344:523-9.
3. 3 Pauwels RA, Lofdahl C-G, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. New Engl J Med 1997;337:1405-11.
4. 4 DerSimontao R, Laird N. Meta-analysis in clinical trials. Contr Clin Trials 1986;7:177-88.
5. 5 Egger M, Smith GD. Meta-analysis bias in location and selection of studies. BMJ 1998;16:61-6.
6. 6 Molier D, Cook DJ, Eastwood S, Olkin I, Rennic D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999;354:1896-900.
7. 7 Ind PW, Dal Negro R, Colman N, Fletcher CP, Browning DC, James MH. Inhaled fluticasone propionate and salmeterol in moderate adult asthma. I. Lung function and symptoms. Am J Resp Crit Care Med 1998;157:A116.
8. 8 Ind PW, Dal Negro R, Colman N, Fletcher CP, Browning DC, James MH. Inhaled fluticasone propionate and salmeterol in moderate adult asthma. II. Exacerbations. Am J Resp Crit Care Med 1998;157:A415.
9. 9 Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-8.
10. 10 Kelsen SG, Church NL, Gillman SA, Lanier BQ, Emmett AH, Rickard KA, et al. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial. J Asthma 1999;36:703-15.
11. 11 Murray JJ, Church NL, Anderson WH, Bernstein DI, Wenzel SE, Emmett A, et al. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases. Allergy Asthma Proc 1999;20:173-80.
12. 12 Kalberg CJ, Nelson H, Yancey S, Petrocella V, Emmett AH, Rickard KA. A comparison of added salmeterol versus increased-dose fluticasone in patients symptomatic on low-dose fluticasone. J Allergy Clin Immunol 1998;101:S6.
13. 13 Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Ann Allergy Asthma Immunol 1999;82:383-9.
14. 14 van Noord JA, Schreurs AJM, Mol SJM, Mulder PGH. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. Thorax 1999;54:207-12.
15. 15 Vermetten FAAM, Boermans AJM, Luiten WDVF, Mulder PGH, Vermue NA. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids. J Asthma 1999;6:97-106.
16. 16 Jenkins C, Gordon I. A meta-analysis investigating the efficacy of adding salmeterol to inhaled corticosteroids (ICS) with doubling the dose of ICS. Am J Respir Crit Care Med 1999;159:A638.